Juvéderm Volbella XC available for use in US

Allergan has announced that its latest filler Juvéderm Volbella XC is now available for use in the US.

The new product can be used for lip augmentation and for correction of perioral rhytids (lipstick lines) in adults over the age of 21.

Clinical trials indicate that Juvéderm Volbella XC efficiently increases lip fullness and softens the appearance of lines around the mouth. It is also approved by the FDA and validated to last through one year for both the lips and perioral rhytids with optimal treatment, claimed the company.

US Medical Aesthetics senior vice-president David Moatazedi said: "We developed a soft, smooth gel appropriate for adding subtle volume to the lips and softening the appearance of perioral lines to address this specific need.

"We are committed to providing our doctors with products to address the evolving needs of their aesthetically-oriented patients."

As per the American Society of Plastic Surgeons (ASPS), use of soft tissue fillers in 2015 was the fastest growing cosmetic minimally-invasive procedure.

Juvéderm Volbella XC is developed with Vycross, a proprietary filler technology from Allergan and is specifically approved for the treatment of lips and perioral rhytids.

Frequent side effects in clinical trials were temporary responses at the treatment site such as swelling, tenderness, bruising, firmness lumps/bumps, redness, pain, discoloration, itching, and dryness. These were resolved within 30 days.